AZN vs RCUS · P/E 28, $288.38B cap vs rev $58.0M
AstraZeneca PLC (AZN) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the AZN and RCUS stock pages for the full models.
Not investment advice.